Heller Ehrman White & McAulife LLP
This article was originally published in The Gray Sheet
Michael Swit, most recently with the San Diego office of McKenna & Cuneo, joins the device and drug regulatory practice of the Washington law firm as special counsel. He will continue to be based in San Diego. Before moving to California in 1999, Swit was affiliated with the Washington office of Burditt & Radizus. He also served as VP and general council of Pharmaceutical Resources, a generic drug firm, and as CEO of Washington Business Information, a publisher of FDA regulatory news...
You may also be interested in...
ASTM International is proposing a new standard that will provide a cleaning agent formula for removing dried blood from stainless steel medical devices.
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.